Lenizak

Tramadol Hydrochloride and Dexketoprofen, the active ingredients in Lenizak, are an opioid analgesic and a non‑steroidal anti‑inflammatory drug presented as oral tablets for oral use. The combination is indicated for the management of moderate to severe acute pain, post‑operative pain, and musculoskeletal pain in adult patients.

GNH USA supplies Lenizak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our network ensures timely delivery, regulatory compliance, and adherence to stringent quality standards across global markets.

Lenizak, a combined opioid‑NSAID analgesic, is indicated for several acute pain conditions.

- Moderate to severe acute pain: provides rapid analgesia by acting on central opioid receptors and reducing peripheral inflammation. - Post‑operative pain: lowers pain intensity after surgical procedures, supporting early mobilization and recovery. - Musculoskeletal pain: eases pain from injuries, sprains, or inflammatory conditions, improving functional ability.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: transient light‑headedness. - Constipation: reduced bowel movements. - Headache: mild throbbing pain. - Somnolence: increased sleepiness. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, especially in high‑dose or opioid‑naïve patients. - Seizures: risk heightened with high tramadol levels or interacting drugs. - Severe allergic reactions: anaphylaxis, skin rash, or angioedema. - Gastrointestinal bleeding or ulceration: due to NSAID component. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: rare severe skin reaction.

Before prescribing Lenizak, clinicians should consider several safety aspects. - Assess renal and hepatic function: adjust use in patients with impairment. - Review seizure history: tramadol may lower seizure threshold. - Check for hypersensitivity: avoid in individuals allergic to tramadol or dexketoprofen. - Monitor for serotonin syndrome: be cautious with serotonergic agents. - Evaluate bleeding risk: NSAID component can increase bleeding tendency. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lenizak may interact with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - SSRIs, SNRIs, or other serotonergic drugs: increased serotonin syndrome potential. - CNS depressants (e.g., benzodiazepines, alcohol): additive sedation and respiratory depression. - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): may raise tramadol plasma concentrations.

Moderate Interactions (Monitor Closely): - Other NSAIDs: heightened gastrointestinal bleeding risk. - Anticoagulants (e.g., warfarin): may potentiate anticoagulant effect. - Antihypertensives: NSAID component can attenuate blood‑pressure control.